| HOME >> BIOLOGY >> TECHNOLOGY |
INTERLEUKIN GENETICS, INC. AND SUBSIDIARIES
FINANCIAL HIGHLIGHTS
Balance Sheet Data:
September 30, December 31,
2007 2006
(Unaudited) (Audited)
Cash and cash equivalents $8,058,276 $10,082,919
Total current assets 10,468,352 12,991,113
Total assets $18,795,836 $22,630,285
Total current liabilities $6,927,948 $7,388,353
Total liabilities 9,157,742 8,844,354
Total shareholders' equity 9,638,094 13,785,931
Total liabilities and shareholders'
equity $18,795,836 $22,630,285
Statement of
Operations Data Three Months Ended Nine Months Ended
(Unaudited): September 30, September 30,
2007 2006 2007 2006
Revenue:
Genetic testing
service revenue $157,645 $654,482 $648,910 $2,219,145
Net consumer
products sales 1,792,688 674,725 5,173,555 674,725
Contract research
revenue 609,234 - 1,558,206 -
Other 1,718 5,724 8,360 17,975
Total revenue 2,561,285 1,334,931 7,389,031 2,911,845
Operating costs and
expenses:
Cost of genetic
testing services 211,953 331,836
'/>"/>
| SOURCE Interleukin Genetics, Inc. Copyright©2007 PR Newswire. All rights reserved |